XML 35 R24.htm IDEA: XBRL DOCUMENT v3.25.1
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES - Revenues disaggregated by our business operations and timing of revenue recognition (Details) - USD ($)
 3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES        
Total $ 983,374 $ 929,631 $ 2,179,991 $ 1,820,795
Research and development services (over-time)        
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES        
Total 133,547 65,200 280,989 142,735
Clinical laboratory testing services (point-in-time)        
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES        
Total   6,440 1,746 18,560
Clinical laboratory testing services (over-time)        
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES        
Total 220,552 324,580 545,132 649,160
Supply chain        
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES        
Total 290,229 275,259 1,013,078 742,746
Large Scale DNA Production        
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES        
Total 333,662 $ 258,152 333,662 258,152
Asset marking        
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES        
Total $ 5,384   $ 5,384 $ 9,442